QTTB Q32 Bio Inc.
Nasdaq · SEC CIK 1661998 · EDGAR
- Bought, last 12 months
- $30.00M 2 purchases by 2 insiders
- Sold, last 12 months
- $459.7K 8 sales by 3 insiders
- Filings on record
- 130 since 2021-09-08, latest 2026-08-27 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Xu Diyong | Dir, 10% | $15.00M | — |
| ORBIMED ADVISORS LLC | Dir, 10% | $15.00M | — |
| Morrison Jodie Pope | CEO, Dir | — | $285.5K |
| Kalowski Lee | CFO, Pres | — | $115.2K |
| Violette Shelia M. | CSO | — | $59.0K |
| Manke Isaac | Dir | — | — |
Transactions 67
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 16:10 | 2026-08-25 | QTTB | Morrison Jodie Pope | CEO, Dir | S - Sale | $16.56 | -9,845 | 343.3K | -3% | -$163.0K | |
| 2026-08-27 16:10 | 2026-08-25 | QTTB | Kalowski Lee | CFO, Pres | S - Sale | $16.56 | -3,972 | 138.5K | -3% | -$65.8K | |
| 2026-08-27 16:10 | 2026-08-25 | QTTB | Violette Shelia M. | CSO | S - Sale | $16.56 | -2,798 | 127.8K | -2% | -$46.3K | |
| 2026-07-20 21:31 | 2026-07-16 | QTTB | Violette Shelia M. | CSO | A - Grant | $0.00 | +37.5K | 130.6K | +40% | $0 | |
| 2026-07-20 21:27 | 2026-07-16 | QTTB | Morrison Jodie Pope | CEO, Dir | A - Grant | $0.00 | +132.0K | 353.1K | +60% | $0 | |
| 2026-07-20 21:25 | 2026-07-16 | QTTB | Kalowski Lee | CFO, Pres | A - Grant | $0.00 | +53.2K | 142.4K | +60% | $0 | |
| D | 2026-07-02 16:30 | 2026-06-30 | QTTB | Manke Isaac | Dir | M - OptEx | $2.80 | +53.5K | 53.5K | New | +$149.9K |
| MI | 2026-06-01 21:15 | 2026-05-28 | QTTB | Xu Diyong | Dir, 10% | P - Purchase | $8.00 | +1.88M | 625.0K | New | +$15.00M |
| MI | 2026-06-01 21:13 | 2026-05-28 | QTTB | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $8.00 | +1.88M | 625.0K | New | +$15.00M |
| 2026-03-20 | 2026-02-24 | QTTB | Violette Shelia M. | CSO | A - Grant | $0.00 | +37.5K | 93.1K | +67% | $0 | |
| 2026-03-20 | 2026-02-24 | QTTB | Kalowski Lee | CFO, Pres | A - Grant | $0.00 | +53.2K | 89.2K | +148% | $0 | |
| 2026-03-20 | 2026-02-24 | QTTB | Morrison Jodie Pope | CEO, Dir | A - Grant | $0.00 | +132.0K | 221.1K | +148% | $0 | |
| 2026-02-27 | 2026-02-25 | QTTB | Violette Shelia M. | CSO | S - Sale | $4.51 | -2,815 | 55.6K | -5% | -$12.7K | |
| 2026-02-27 | 2026-02-25 | QTTB | Kalowski Lee | CFO, Pres | S - Sale | $4.51 | -3,995 | 35.9K | -10% | -$18.0K | |
| 2026-02-27 | 2026-02-25 | QTTB | Morrison Jodie Pope | CEO, Dir | S - Sale | $4.51 | -9,896 | 89.1K | -10% | -$44.6K | |
| 2025-12-04 | 2025-12-02 | QTTB | Kalowski Lee | CFO, Pres | S - Sale | $3.46 | -9,072 | 39.9K | -19% | -$31.4K | |
| 2025-12-04 | 2025-12-02 | QTTB | Morrison Jodie Pope | CEO, Dir | S - Sale | $3.46 | -22.5K | 99.0K | -19% | -$77.9K | |
| 2025-08-28 | 2025-08-26 | QTTB | Morrison Jodie Pope | CEO, Dir | S - Sale | $1.80 | -10.5K | 121.5K | -8% | -$18.9K | |
| 2025-08-28 | 2025-08-26 | QTTB | Kalowski Lee | CFO, Pres | S - Sale | $1.80 | -4,240 | 49.0K | -8% | -$7,632 | |
| 2025-08-28 | 2025-08-26 | QTTB | Violette Shelia M. | CSO | S - Sale | $1.80 | -2,990 | 58.4K | -5% | -$5,382 | |
| D | 2025-02-27 | 2025-02-24 | QTTB | Kalowski Lee | CFO, Pres | A - Grant | $0.00 | +53.2K | 53.2K | New | $0 |
| D | 2025-02-26 | 2025-02-24 | QTTB | Violette Shelia M. | CSO | A - Grant | $0.00 | +37.5K | 61.4K | +157% | $0 |
| D | 2025-02-26 | 2025-02-24 | QTTB | Morrison Jodie Pope | CEO, Dir | A - Grant | $0.00 | +132.0K | 132.0K | New | $0 |
| D | 2025-02-26 | 2025-02-24 | QTTB | Campagna Jason | Chief Medical Off | A - Grant | $0.00 | +37.5K | 37.5K | New | $0 |
| DM | 2024-10-16 | 2024-10-11+ | QTTB | Violette Shelia M. | CSO | M - OptEx | $5.49 | +10.6K | 23.9K | +80% | +$58.0K |
| D | 2024-10-10 | 2024-10-08 | QTTB | Violette Shelia M. | CSO | M - OptEx | $3.12 | +13.3K | 13.3K | New | +$41.5K |
| D | 2024-08-14 | 2024-03-25 | QTTB | TZIANABOS ARTHUR | Dir | M - OptEx | — | +1,095 | 8,248 | +15% | — |
| D | 2024-08-14 | 2024-03-25 | QTTB | TZIANABOS ARTHUR | Dir | S - Sale+OE | $24.20 | -265 | 7,983 | -3% | -$6,413 |
| 2024-04-23 | 2024-03-25 | QTTB | Michaud Charles Jr | See Remarks | S - Sale | $24.20 | -75 | 927 | -7% | -$1,815 | |
| 2024-04-23 | 2024-03-25 | QTTB | Alloway Paul | See Remarks | S - Sale | $24.21 | -268 | 2,596 | -9% | -$6,488 | |
| D | 2024-03-27 | 2024-03-25 | QTTB | Alloway Paul | See Remarks | M - OptEx | — | +23.5K | 51.6K | +84% | — |
| D | 2024-03-27 | 2024-03-25 | QTTB | Michaud Charles Jr | See Remarks | M - OptEx | — | +6,448 | 18.0K | +56% | — |
| DMT | 2024-02-15 | 2024-01-01 | QTTB | TZIANABOS ARTHUR | Dir | M - OptEx | — | +33.4K | 122.7K | +37% | — |
| DT | 2024-02-15 | 2024-01-09 | QTTB | TZIANABOS ARTHUR | Dir | S - Sale+OE | $0.57 | -13.0K | 128.8K | -9% | -$7,431 |
| 2024-01-05 | 2024-01-03 | QTTB | Michaud Charles Jr | See Remarks | S - Sale | $0.57 | -1,708 | 11.6K | -13% | -$973.56 | |
| 2024-01-05 | 2024-01-03 | QTTB | Alloway Paul | See Remarks | S - Sale | $0.57 | -7,280 | 28.0K | -21% | -$4,150 | |
| DM | 2024-01-03 | 2024-01-01 | QTTB | Alloway Paul | See Remarks | M - OptEx | — | +18.6K | 35.3K | +111% | — |
| DM | 2024-01-03 | 2024-01-01 | QTTB | Michaud Charles Jr | See Remarks | M - OptEx | — | +4,240 | 10.7K | +66% | — |
| DT | 2023-09-08 | 2023-09-06 | QTTB | Seymour Albert | See Remarks, Dir | M - OptEx | — | +4,620 | 152.3K | +3% | — |
| DT | 2023-09-08 | 2023-09-06 | QTTB | Seymour Albert | See Remarks, Dir | S - Sale+OE | $1.15 | -1,448 | 150.9K | -1.0% | -$1,665 |
| DMT | 2023-08-07 | 2023-08-03 | QTTB | Jordan Julie | Chief Medical Off | M - OptEx | $0.00 | +6,579 | 4,269 | New | $0 |
| DMT | 2023-08-07 | 2023-08-03 | QTTB | Jordan Julie | Chief Medical Off | S - Sale+OE | $1.39 | -1,853 | 4,160 | -31% | -$2,576 |
| DT | 2023-08-04 | 2023-08-02 | QTTB | Jordan Julie | Chief Medical Off | S - Sale+OE | $1.31 | -99 | 2,770 | -3% | -$129.69 |
| DT | 2023-08-04 | 2023-08-02 | QTTB | Jordan Julie | Chief Medical Off | M - OptEx | $0.00 | +350 | 2,869 | +14% | $0 |
| 2023-03-06 | 2023-03-02 | QTTB | Alloway Paul | See Remarks | S - Sale | $1.45 | -11.0K | 16.7K | -40% | -$15.9K | |
| 2023-01-11 | 2023-01-09 | QTTB | Blum Michael Lee | Chief Commercial Off | S - Sale | $1.39 | -2,454 | 13.5K | -15% | -$3,411 | |
| 2023-01-11 | 2023-01-09 | QTTB | Seymour Albert | See Remarks, Dir | S - Sale | $1.39 | -3,620 | 143.2K | -2% | -$5,032 | |
| 2023-01-11 | 2023-01-09 | QTTB | TZIANABOS ARTHUR | Dir | S - Sale | $1.39 | -10.6K | 108.4K | -9% | -$14.8K | |
| 2023-01-11 | 2023-01-09 | QTTB | Alloway Paul | See Remarks | S - Sale | $1.39 | -3,090 | 20.1K | -13% | -$4,295 | |
| 2023-01-11 | 2023-01-09 | QTTB | Smith W Bradford | See Remarks | S - Sale | $1.39 | -3,729 | 14.2K | -21% | -$5,183 | |
| DM | 2023-01-04 | 2023-01-01 | QTTB | Smith W Bradford | See Remarks | M - OptEx | — | +13.5K | 17.9K | +306% | — |
| DM | 2023-01-04 | 2023-01-01 | QTTB | Seymour Albert | See Remarks, Dir | M - OptEx | — | +11.2K | 146.8K | +8% | — |
| DM | 2023-01-04 | 2023-01-01 | QTTB | TZIANABOS ARTHUR | Dir | M - OptEx | — | +33.0K | 119.0K | +38% | — |
| DM | 2023-01-04 | 2023-01-01 | QTTB | Blum Michael Lee | Chief Commercial Off | M - OptEx | — | +7,590 | 11.0K | +220% | — |
| DM | 2023-01-04 | 2023-01-01 | QTTB | Alloway Paul | See Remarks | M - OptEx | — | +9,570 | 23.2K | +70% | — |
| D | 2022-01-12 | 2022-01-01 | QTTB | Cohn Gabriel | Chief Medical Off | M - OptEx | — | +4,290 | 4,290 | New | — |
| D | 2022-01-12 | 2022-01-05 | QTTB | Cohn Gabriel | Chief Medical Off | S - Sale+OE | $3.78 | -1,661 | 2,629 | -39% | -$6,279 |
| D | 2022-01-12 | 2022-01-01 | QTTB | Smith W Bradford | CFO, Treas | M - OptEx | — | +6,600 | 6,600 | New | — |
| D | 2022-01-12 | 2022-01-05 | QTTB | Smith W Bradford | CFO, Treas | S - Sale+OE | $3.78 | -2,182 | 4,418 | -33% | -$8,248 |
| D | 2022-01-12 | 2022-01-01 | QTTB | TZIANABOS ARTHUR | Pres, CEO, Dir | M - OptEx | — | +13.9K | 91.4K | +18% | — |
| D | 2022-01-12 | 2022-01-05 | QTTB | TZIANABOS ARTHUR | Pres, CEO, Dir | S - Sale+OE | $3.78 | -5,354 | 86.0K | -6% | -$20.2K |
| D | 2022-01-12 | 2022-01-05 | QTTB | Seymour Albert | CSO | S - Sale+OE | $3.78 | -1,661 | 131.6K | -1% | -$6,279 |
| D | 2022-01-12 | 2022-01-01 | QTTB | Seymour Albert | CSO | M - OptEx | — | +4,290 | 133.3K | +3% | — |
| D | 2022-01-12 | 2022-01-01 | QTTB | Kelly Timothy P | COO | M - OptEx | — | +3,630 | 3,630 | New | — |
| D | 2022-01-12 | 2022-01-05 | QTTB | Kelly Timothy P | COO | S - Sale+OE | $3.78 | -1,406 | 2,224 | -39% | -$5,315 |
| A | 2021-09-08 | 2021-03-01 | QTTB | Kelly Timothy P | See Remarks | S - Sale | $11.16 | -6,232 | 0 | -100% | -$69.5K |
| 2021-09-08 | 2021-09-03 | QTTB | Kelly Timothy P | See Remarks | S - Sale | $7.70 | -54 | 0 | -100% | -$415.80 |